Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Nephron
|
January 1, 1994
Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis
J Hegbrant, H Thysell, L Mårtensson, et al.
Acta Anaesthesiologica Scandinavica. Supplementum
|
January 1, 1995
Oxygen status during haemodialysis. The Cord-Group
A L Nielsen, H A Jensen, J Hegbrant, et al.
Blood Purification
|
January 1, 1997
Beneficial effect of cold dialysate for the prevention of hemodialysis-induced hypoxia
J Hegbrant, J Sternby, A Larsson, et al.
Blood Purification
|
September 24, 1999
Assessment of pH and oxygen status during hemodialysis using the arterial blood line in patients with an arteriovenous fistula
A L Nielsen, P Thunedborg, H Brinkenfeldt, et al.
Metabolism: Clinical and Experimental
|
March 27, 1999
Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: relation to apolipoprotein(a) size polymorphism
M Arnadottir, A L Berg, F Kronenberg, et al.
Clinical Nephrology
|
January 1, 1997
Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis
M Hultqvist, J Hegbrant, C Nilsson-Thorell, et al.
The Journal of Pharmacy and Pharmacology
|
August 1, 1995
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure
S G Woolfrey, J Hegbrant, H Thysell, et al.
Kidney International Reports
|
November 29, 2023
High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial
Robin W M Vernooij, C Hockham, C Barth, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]
V Saglimbene, D D'Alonzo, M Ruospo, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Nephron
|
January 1, 1994
Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis
J Hegbrant, H Thysell, L Mårtensson, et al.
Acta Anaesthesiologica Scandinavica. Supplementum
|
January 1, 1995
Oxygen status during haemodialysis. The Cord-Group
A L Nielsen, H A Jensen, J Hegbrant, et al.
Blood Purification
|
January 1, 1997
Beneficial effect of cold dialysate for the prevention of hemodialysis-induced hypoxia
J Hegbrant, J Sternby, A Larsson, et al.
Blood Purification
|
September 24, 1999
Assessment of pH and oxygen status during hemodialysis using the arterial blood line in patients with an arteriovenous fistula
A L Nielsen, P Thunedborg, H Brinkenfeldt, et al.
Metabolism: Clinical and Experimental
|
March 27, 1999
Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: relation to apolipoprotein(a) size polymorphism
M Arnadottir, A L Berg, F Kronenberg, et al.
Clinical Nephrology
|
January 1, 1997
Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis
M Hultqvist, J Hegbrant, C Nilsson-Thorell, et al.
The Journal of Pharmacy and Pharmacology
|
August 1, 1995
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure
S G Woolfrey, J Hegbrant, H Thysell, et al.
Kidney International Reports
|
November 29, 2023
High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial
Robin W M Vernooij, C Hockham, C Barth, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]
V Saglimbene, D D'Alonzo, M Ruospo, et al.
Page
of 3